|
Sept 19, 2011
Tropical Health enters license agreement negotiation with the Office of Technology Transfer at Carnegie Mellon University for the right to develop and commercialize pScreen™.
March 15, 2009
Tropical Health initiates the prototype development phase in partnership with the Biomedical Engineering Department at Carnegie Mellon University.
February 9, 2009
Tropical Health receives the Enterprise Creation Award from Carnegie Mellon Center for Technology Transfer to develop the alfa prototype.
March 15, 2008
Tropical Health wins first place in the life sciences category at the McGinnis Venture Competition at Carnegie Mellon University. |
Tropical Health Systems is an early-stage medical technology company developing pScreen™, a disruptive solution for the screening and detection of diseases and illness at the Point-of-Care.
Tropical Health's proprietary microfluidic technology was developed in Laboratory for Innovation and Optimization of Medical Device at the Department of Biomedical Engineering, Carnegie Mellon University.
The company's R&D approach is focused on delivering easy-to-use, handset- and power-free, robust, low-cost, point-of-care diagnostic immunoassays.
Our company's vision is to be a leader in the fast growing global point-of-care diagnostic market estimated to be $15 billion annually with an estimated CAGR of 6% through 2015.
Click here to learn more.
|